 well tolerated but is of no proven beneÔ¨Åt.
4B. Pharmacotherapy for patients with IC to improve
leg function
Medical management of IC is aimed at symptom relief
(Table II) and slowing the progression of atherosclerotic disease. A number of drugs have been evaluated for use in patients with IC, but in the United States, there are currently
only two Food and Drug Administration (FDA)-approved
medicationsdcilostazol and pentoxifylline